Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease

被引：3
|
作者：
Tamaki, Nobuharu [1 ]
Kurosaki, Masayuki [1 ]
Higuchi, Mayu [1 ]
Izumi, Namiki [1 ]
机构：
[1] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, 1-26-1 Kyonancho, Musashino, Tokyo 1808610, Japan
来源：
HEPATOLOGY RESEARCH | 2021年 / 51卷 / 11期
关键词：
cardiovascular disease (CVD); liver fibrosis; metabolic dysfunction associated fatty liver disease (MAFLD); nonalcoholic fatty liver disease (NAFLD);
D O I：
10.1111/hepr.13700
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1172 / 1173
页数：2
相关论文
共 50 条
  • [21] Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
    Lee, Hokyou
    Lee, Yong-ho
    Kim, Seung Up
    Kim, Hyeon Chang
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (10) : 2138 - +
  • [22] METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE AND ITS EFFECT ON CARDIOVASCULAR DISEASE RISK IN PATIENTS WITH HCV
    Elgretli, Wesal
    Shengir, Mohamed
    Sasson, Solomon
    Ballesteros, Luz Ramos
    Wong, Philip
    Chen, Tianyan
    Deschenes, Marc
    Sebastiani, Giada
    [J]. HEPATOLOGY, 2023, 78 : S1010 - S1011
  • [23] From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease: Out with the Old, in with the New
    Razzak, Iyiad Alabdul
    Noureddin, Mazen
    Trivedi, Hirsh D.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [24] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [25] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Ting-Yao Wang
    Rui-Fang Wang
    Zhi-Ying Bu
    Giovanni Targher
    Christopher D. Byrne
    Dan-Qin Sun
    Ming-Hua Zheng
    [J]. Nature Reviews Nephrology, 2022, 18 : 259 - 268
  • [26] The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
    Barrera, Francisco
    Uribe, Javier
    Olvares, Nixa
    Huerta, Paula
    Cabrera, Daniel
    Romero-Gomez, Manuel
    [J]. ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [27] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Wang, Ting-Yao
    Wang, Rui-Fang
    Bu, Zhi-Ying
    Targher, Giovanni
    Byrne, Christopher D.
    Sun, Dan-Qin
    Zheng, Ming-Hua
    [J]. NATURE REVIEWS NEPHROLOGY, 2022, 18 (04) : 259 - 268
  • [28] Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Choi, Sung Chul
    Goh, Myung Ji
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    [J]. JHEP REPORTS, 2023, 5 (09)
  • [29] Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
    Yoon, Eileen Laurel
    Jun, Dae Won
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (02) : 371 - 373
  • [30] Changing Nomenclature from Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Fatty Liver Disease - Not Only Premature But Also Confusing
    Duseja, Ajay
    Taneja, Sunil
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 11 (02) : 278 - 279
12345